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A better understanding of the microenvironment in
relation to lymph node metastasis is essential for the
development of effective immunotherapeutic strategies
against cervical cancer.
In the present study, we investigated the microenvir-
onment of tumor-draining lymph nodes of cervical can-
cer patients, by comprehensive flow cytometry-based
phenotyping and enumeration of immune-cell subsets in
tumor-negative (LN-, n = 20) versus tumor-positive
lymph nodes (LN+, n = 8), and by the study of cytokine
release profiles (n = 4 for both LN- and LN+).
We found significantly lower CD4+ and higher CD8+
T-cell frequencies in LN+ samples, accompanied by
increased surface levels of activation (HLA-DR and ICOS)
and inhibitory markers (PD-1 and CTLA-4). Furthermore,
in LN+ we found increased rates of a potentially regula-
tory antigen-presenting cell (APC) subset (CD11chiCD14
+PD-L1+) and of myeloid-derived suppressor cell (MDSC)
subsets, which in the case of the former correlated signifi-
cantly with elevated frequencies of FoxP3+ Tregs. After in
vitro stimulation with different TLR ligands (PGN; Poly-
IC; R848), we observed higher production levels of IL-6,
IL-10 and TNFa but lower levels of IFNg in LN+.
We conclude that, despite increased T-cell differentia-
tion and activation, a striking switch to a profound
immune suppressive microenvironment in LN+ of cervical
cancer patients will enable immune escape. Our data point
to the CD14+PD-L1+ APC/Treg axis as a particularly
attractive and relevant therapeutic target to specifically
tackle microenvironmental immune suppression and thus
enhance the efficacy of immunotherapy in patients with
metastasized cervical cancer.
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